https://www.selleckchem.com/pr....oducts/5-n-ethylcarb
The nomogram displayed fairly good discrimination and calibration. The C-index value was 0.742 for the training cohort and 0.773 for the validation cohort. Patients were grouped into three risk groups very well by the nomogram, with 5-year PRS rates of 45.2%, 23.3%, and 9.0%, respectively (p0.001) in the training cohort and 36.0%, 9.2%, and 4.6%, respectively (p0.001) in the validation cohort. A novel nomogram was built and validated to enable the prediction of personal PRS in CRLM patients with post-hepate